USPH
U.S. Physical Therapy, Inc.
Price Chart
Latest Quote
$63.74
| Previous Close | $66.39 |
| Open | $65.97 |
| Day High | $66.92 |
| Day Low | $63.44 |
| Volume | 122,147 |
Stock Information
| Quarterly Dividend / Yield | $1.82 / 2.74% |
| Shares Outstanding | 15.22M |
| Quarterly Dividend Yield | 2.74% |
| Quarterly Dividend | $1.82 |
| Total Debt | $362.83M |
| Cash Equivalents | $29.49M |
| Revenue | $787.68M |
| Net Income | $7.67M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $970.05M |
| P/E Ratio | 127.48 |
| EPS (TTM) | $0.50 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.66B |
| Sales | $787.68M |
| Income | $7.67M |
| Book/sh | $31.50 |
| Cash/sh | $1.94 |
| Employees | 5K |
Financial Ratios
| Quick Ratio | 1.08 |
| Current Ratio | 1.19 |
| Debt/Eq | 46.35 |
| EPS Growth TTM | -49.10% |
Returns & Margins
| ROA | 4.13% |
| ROE | 6.83% |
| Gross Margin | 21.90% |
| Operating Margin | 7.34% |
| Profit Margin | 4.41% |
Ownership
| Insider Ownership | 2.47% |
| Institutional Ownership | 108.39% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 18.68 |
| PEG | 2.41 |
| P/S | 1.23 |
| P/B | 2.02 |
Analyst Data
| Recommendation | none |
| Target Price | $93.67 |
Technical Indicators
| SMA20 | $63.28 |
| SMA50 | $67.44 |
| SMA200 | $77.01 |
| RSI | 49.50 |
| ATR | 2.2918 |
| Shares Float | 14.84M |
| Short Float | 8.18% |
| Short Ratio | 3.99 |
| Volatility | 1.16 |
| Rel Volume | 0.65 |
Performance History
| Week | +1.45% |
| Month | -1.28% |
| Quarter | -14.64% |
| 6 Months | -20.40% |
| YTD | -18.11% |
| Year | -15.51% |
| 3 Years | -38.13% |
| 5 Years | -40.38% |
| 10 Years | +28.04% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $63.74 | 122,147 |
| 2026-06-16 | $66.39 | 137,400 |
| 2026-06-15 | $65.52 | 262,800 |
| 2026-06-12 | $65.56 | 146,400 |
| 2026-06-11 | $65.79 | 192,400 |
| 2026-06-10 | $62.83 | 223,900 |
| 2026-06-09 | $61.80 | 171,200 |
| 2026-06-08 | $61.30 | 218,900 |
| 2026-06-05 | $63.45 | 132,900 |
| 2026-06-04 | $61.77 | 192,000 |
| 2026-06-03 | $61.87 | 186,400 |
| 2026-06-02 | $62.50 | 139,500 |
| 2026-06-01 | $62.53 | 266,800 |
| 2026-05-29 | $64.26 | 195,900 |
| 2026-05-28 | $63.89 | 199,700 |
| 2026-05-27 | $64.17 | 188,900 |
| 2026-05-26 | $62.11 | 158,100 |
| 2026-05-22 | $61.96 | 140,000 |
| 2026-05-21 | $62.39 | 297,400 |
| 2026-05-20 | $61.78 | 213,300 |
| 2026-05-19 | $61.16 | 218,700 |
| 2026-05-18 | $64.56 | 402,600 |
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
đ° Latest News
1 Cash-Producing Stock Worth Investigating and 2 We Turn Down
StockStory âĸ 2026-06-17T08:44:51ZHow The Story Is Shifting For U.S. Physical Therapy (USPH) As Price Targets Reset
Simply Wall St. âĸ 2026-06-01T00:14:18Z3 Reasons USPH is Risky and 1 Stock to Buy Instead
StockStory âĸ 2026-05-21T04:52:55ZDo These 3 Checks Before Buying U.S. Physical Therapy, Inc. (NYSE:USPH) For Its Upcoming Dividend
Simply Wall St. âĸ 2026-05-18T12:46:00ZStocks making big moves yesterday: Helios, DraftKings, CACI, U.S. Physical Therapy, and Ulta
StockStory âĸ 2026-05-17T04:28:55ZU.S. Physical Therapyâs Q1 Earnings Call: Our Top 5 Analyst Questions
StockStory âĸ 2026-05-17T00:20:55ZU.S. Physical Therapy (USPH) Stock Is Up, What You Need To Know
StockStory âĸ 2026-05-16T04:36:55ZU.S. Physical Therapy (USPH) Q1 Earnings and Revenues Lag Estimates
Zacks âĸ 2026-05-07T01:45:12ZHere's What Key Metrics Tell Us About U.S. Physical Therapy (USPH) Q1 Earnings
Zacks âĸ 2026-05-06T23:00:04ZU.S. Physical Therapyâs (NYSE:USPH) Q1 CY2026 Earnings Results: Revenue In Line With Expectations
StockStory âĸ 2026-05-06T22:11:03ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $631,297,000 | $547,424,000 | $483,293,000 | $441,120,000 |
| Cost Of Revenue | $631,297,000 | $547,424,000 | $483,293,000 | $441,120,000 |
| Total Revenue | $780,990,000 | $671,345,000 | $604,802,000 | $553,144,000 |
| Operating Revenue | $650,429,000 | $560,553,000 | $514,556,000 | $464,590,000 |
| Expenses | ||||
| Interest Expense | $9,459,000 | $8,015,000 | $9,303,000 | $5,779,000 |
| Total Expenses | $700,557,000 | $605,714,000 | $534,779,000 | $487,231,000 |
| Rent Expense Supplemental | $140,431,000 | $118,910,000 | $108,596,000 | $102,370,000 |
| Other Income Expense | $6,734,000 | $-1,348,000 | $-15,118,000 | $-4,563,000 |
| Other Non Operating Income Expenses | $458,000 | $357,000 | $390,000 | $859,000 |
| Net Non Operating Interest Income Expense | $-9,354,000 | $-4,074,000 | $-5,529,000 | $-5,779,000 |
| Interest Expense Non Operating | $9,459,000 | $8,015,000 | $9,303,000 | $5,779,000 |
| Operating Expense | $69,260,000 | $58,290,000 | $51,486,000 | $46,111,000 |
| Other Operating Expenses | $69,260,000 | $58,290,000 | $51,486,000 | $46,111,000 |
| General And Administrative Expense | - | - | - | $46,111,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $15,062,000 | $26,460,000 | $14,674,000 | $28,268,000 |
| Net Interest Income | $-9,354,000 | $-4,074,000 | $-5,529,000 | $-5,779,000 |
| Interest Income | $105,000 | $3,941,000 | $3,774,000 | $0 |
| Normalized Income | $11,484,629 | $28,519,267 | $26,181,637 | $33,057,422 |
| Net Income From Continuing And Discontinued Operation | $15,062,000 | $26,460,000 | $14,674,000 | $28,268,000 |
| Total Operating Income As Reported | $86,677,000 | $62,994,000 | $50,511,000 | $56,801,000 |
| Net Income Common Stockholders | $21,572,000 | $27,728,000 | $18,140,000 | $29,262,000 |
| Net Income | $15,062,000 | $26,460,000 | $14,674,000 | $28,268,000 |
| Net Income Including Noncontrolling Interests | $58,005,000 | $45,600,000 | $37,220,000 | $43,407,000 |
| Net Income Continuous Operations | $58,005,000 | $45,600,000 | $37,220,000 | $43,407,000 |
| Pretax Income | $77,813,000 | $60,209,000 | $49,376,000 | $55,571,000 |
| Special Income Charges | $6,121,000 | $-2,637,000 | $-19,045,000 | $-6,592,000 |
| Earnings From Equity Interest | $1,477,000 | $1,014,000 | $955,000 | $1,175,000 |
| Interest Income Non Operating | $105,000 | $3,941,000 | $3,774,000 | $0 |
| Operating Income | $80,433,000 | $65,631,000 | $70,023,000 | $65,913,000 |
| Gross Profit | $149,693,000 | $123,921,000 | $121,509,000 | $112,024,000 |
| Per Share | ||||
| Diluted EPS | $1.42 | $1.84 | $1.28 | $2.25 |
| Basic EPS | $1.42 | $1.84 | $1.28 | $2.25 |
| Other | ||||
| Tax Effect Of Unusual Items | $1,221,629 | $-659,733 | $-4,955,363 | $-1,807,578 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $104,864,000 | $89,624,000 | $90,837,000 | $82,690,000 |
| Total Unusual Items | $4,799,000 | $-2,719,000 | $-16,463,000 | $-6,597,000 |
| Total Unusual Items Excluding Goodwill | $4,799,000 | $-2,719,000 | $-16,463,000 | $-6,597,000 |
| Reconciled Depreciation | $22,391,000 | $18,681,000 | $15,695,000 | $14,743,000 |
| EBITDA (Bullshit earnings) | $109,663,000 | $86,905,000 | $74,374,000 | $76,093,000 |
| EBIT | $87,272,000 | $68,224,000 | $58,679,000 | $61,350,000 |
| Diluted Average Shares | $15,175,000 | $15,064,000 | $14,188,000 | $12,985,000 |
| Basic Average Shares | $15,175,000 | $15,064,000 | $14,188,000 | $12,985,000 |
| Diluted NI Availto Com Stockholders | $21,572,000 | $27,728,000 | $18,140,000 | $29,262,000 |
| Otherunder Preferred Stock Dividend | $-6,510,000 | $-1,268,000 | $-3,466,000 | $-994,000 |
| Minority Interests | $-42,943,000 | $-19,140,000 | $-22,546,000 | $-15,139,000 |
| Tax Provision | $19,808,000 | $14,609,000 | $12,156,000 | $12,164,000 |
| Gain On Sale Of Business | $-123,000 | $0 | $0 | $0 |
| Write Off | $0 | $2,418,000 | $0 | $0 |
| Impairment Of Capital Assets | $0 | $0 | $17,495,000 | $9,112,000 |
| Restructuring And Mergern Acquisition | $-6,244,000 | $219,000 | $1,550,000 | $-2,520,000 |
| Gain On Sale Of Security | $-1,322,000 | $-82,000 | $2,582,000 | $-5,000 |
| Selling General And Administration | - | - | - | $46,111,000 |
| Other Gand A | - | - | - | $46,111,000 |
| Other Special Charges | - | - | - | - |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-388,821,000 | $-357,534,000 | $-143,059,000 | $-287,063,000 |
| Total Assets | $1,204,010,000 | $1,167,467,000 | $997,238,000 | $858,154,000 |
| Total Non Current Assets | $1,064,020,000 | $1,029,884,000 | $763,863,000 | $746,888,000 |
| Other Non Current Assets | $6,644,000 | $5,155,000 | $2,821,000 | $4,149,000 |
| Goodwill And Other Intangible Assets | $865,253,000 | $846,463,000 | $619,253,000 | $602,856,000 |
| Other Intangible Assets | $172,861,000 | $179,311,000 | $109,682,000 | $108,755,000 |
| Current Assets | $139,990,000 | $137,583,000 | $233,375,000 | $111,266,000 |
| Other Current Assets | $16,084,000 | $10,555,000 | $10,830,000 | $11,067,000 |
| Receivables | $88,336,000 | $85,666,000 | $69,720,000 | $68,605,000 |
| Other Receivables | $24,087,000 | $26,626,000 | $17,854,000 | $16,671,000 |
| Accounts Receivable | $64,249,000 | $59,040,000 | $51,866,000 | $68,605,000 |
| Allowance For Doubtful Accounts Receivable | $-3,775,000 | $-3,506,000 | $-2,736,000 | $-2,829,000 |
| Gross Accounts Receivable | $68,024,000 | $62,546,000 | $54,602,000 | $71,434,000 |
| Cash Cash Equivalents And Short Term Investments | $35,570,000 | $41,362,000 | $152,825,000 | $31,594,000 |
| Cash And Cash Equivalents | $35,570,000 | $41,362,000 | $152,825,000 | $31,594,000 |
| Debt | ||||
| Net Debt | $126,889,000 | $112,167,000 | - | $152,100,000 |
| Total Debt | $315,165,000 | $295,232,000 | $258,587,000 | $295,337,000 |
| Long Term Debt And Capital Lease Obligation | $263,166,000 | $244,398,000 | $215,644,000 | $253,765,000 |
| Long Term Debt | $152,594,000 | $142,530,000 | $138,991,000 | $175,831,000 |
| Current Debt And Capital Lease Obligation | $51,999,000 | $50,834,000 | $42,943,000 | $41,572,000 |
| Current Debt | $9,865,000 | $10,999,000 | $7,691,000 | $7,863,000 |
| Other Current Borrowings | $9,865,000 | $10,999,000 | $7,691,000 | $7,863,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $433,811,000 | $408,421,000 | $345,000,000 | $373,586,000 |
| Total Non Current Liabilities Net Minority Interest | $294,771,000 | $292,138,000 | $242,815,000 | $288,097,000 |
| Other Non Current Liabilities | $3,214,000 | $18,275,000 | $2,356,000 | $13,029,000 |
| Non Current Deferred Liabilities | $28,391,000 | $29,465,000 | $24,815,000 | $21,303,000 |
| Non Current Deferred Taxes Liabilities | $28,391,000 | $29,465,000 | $24,815,000 | $21,303,000 |
| Current Liabilities | $139,040,000 | $116,283,000 | $102,185,000 | $85,489,000 |
| Payables And Accrued Expenses | $87,041,000 | $65,449,000 | $59,242,000 | $43,917,000 |
| Interest Payable | $393,000 | $402,000 | $235,000 | $273,000 |
| Payables | $38,186,000 | $20,253,000 | $26,391,000 | $15,495,000 |
| Other Payable | $30,821,000 | $9,402,000 | $21,132,000 | $8,714,000 |
| Total Tax Payable | $1,306,000 | $4,915,000 | $1,361,000 | $277,000 |
| Income Tax Payable | $993,000 | $4,544,000 | $1,006,000 | $0 |
| Accounts Payable | $6,059,000 | $5,936,000 | $3,898,000 | $6,504,000 |
| Equity | ||||
| Common Stock Equity | $476,432,000 | $488,929,000 | $476,194,000 | $315,793,000 |
| Total Equity Gross Minority Interest | $770,199,000 | $759,046,000 | $652,238,000 | $484,568,000 |
| Stockholders Equity | $476,432,000 | $488,929,000 | $476,194,000 | $315,793,000 |
| Gains Losses Not Affecting Retained Earnings | $714,000 | $2,799,000 | $2,782,000 | $4,004,000 |
| Other Equity Adjustments | $714,000 | $2,799,000 | $2,782,000 | $4,004,000 |
| Retained Earnings | $227,216,000 | $227,265,000 | $223,772,000 | $232,948,000 |
| Long Term Equity Investment | $12,275,000 | $12,190,000 | $12,256,000 | $12,131,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $2,296,059 | $2,214,737 | $2,214,737 | $2,214,737 |
| Ordinary Shares Number | $15,122,562 | $15,094,383 | $14,987,554 | $13,001,589 |
| Share Issued | $17,418,621 | $17,309,120 | $17,202,291 | $15,216,326 |
| Tangible Book Value | $-388,821,000 | $-357,534,000 | $-143,059,000 | $-287,063,000 |
| Invested Capital | $638,891,000 | $642,458,000 | $622,876,000 | $499,487,000 |
| Working Capital | $950,000 | $21,300,000 | $131,190,000 | $25,777,000 |
| Capital Lease Obligations | $152,706,000 | $141,703,000 | $111,905,000 | $111,643,000 |
| Total Capitalization | $629,026,000 | $631,459,000 | $615,185,000 | $491,624,000 |
| Minority Interest | $293,767,000 | $270,117,000 | $176,044,000 | $168,775,000 |
| Treasury Stock | $37,194,000 | $31,628,000 | $31,628,000 | $31,628,000 |
| Additional Paid In Capital | $285,522,000 | $290,321,000 | $281,096,000 | $110,317,000 |
| Capital Stock | $174,000 | $172,000 | $172,000 | $152,000 |
| Common Stock | $174,000 | $172,000 | $172,000 | $152,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $110,572,000 | $101,868,000 | $76,653,000 | $77,934,000 |
| Current Capital Lease Obligation | $42,134,000 | $39,835,000 | $35,252,000 | $33,709,000 |
| Current Accrued Expenses | $48,855,000 | $45,196,000 | $32,851,000 | $28,422,000 |
| Investments And Advances | $12,275,000 | $12,190,000 | $12,256,000 | $12,131,000 |
| Goodwill | $692,392,000 | $667,152,000 | $509,571,000 | $494,101,000 |
| Net PPE | $179,848,000 | $166,076,000 | $129,533,000 | $127,752,000 |
| Accumulated Depreciation | $-91,225,000 | $-87,093,000 | $-84,821,000 | $-80,203,000 |
| Gross PPE | $271,073,000 | $253,169,000 | $214,354,000 | $207,955,000 |
| Leases | $58,985,000 | $51,105,000 | $46,941,000 | $42,877,000 |
| Other Properties | $144,197,000 | $133,936,000 | $103,431,000 | $103,004,000 |
| Machinery Furniture Equipment | $67,891,000 | $68,128,000 | $63,982,000 | $62,074,000 |
| Properties | $0 | $0 | $0 | $0 |
| Investmentsin Associatesat Cost | - | - | - | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $60,987,000 | $65,754,000 | $72,684,000 | $50,289,000 |
| Operating Activities | ||||
| Operating Cash Flow | $75,058,000 | $74,940,000 | $81,978,000 | $58,537,000 |
| Cash Flow From Continuing Operating Activities | $75,058,000 | $74,940,000 | $81,978,000 | $58,537,000 |
| Operating Gains Losses | $-1,094,000 | $-178,000 | $-789,000 | $-1,818,000 |
| Investing Activities | ||||
| Capital Expenditure | $-14,071,000 | $-9,186,000 | $-9,294,000 | $-8,248,000 |
| Investing Cash Flow | $-36,713,000 | $-149,450,000 | $-45,015,000 | $-81,269,000 |
| Cash Flow From Continuing Investing Activities | $-36,713,000 | $-149,450,000 | $-45,015,000 | $-81,269,000 |
| Net Other Investing Changes | $895,000 | $694,000 | $321,000 | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-5,566,000 | $0 | $0 | - |
| Issuance Of Capital Stock | $0 | $0 | $163,646,000 | $0 |
| Financing Cash Flow | $-44,137,000 | $-36,953,000 | $84,268,000 | $25,759,000 |
| Cash Flow From Continuing Financing Activities | $-44,137,000 | $-36,953,000 | $84,268,000 | $25,759,000 |
| Net Other Financing Charges | $-19,269,000 | $-14,711,000 | $-16,100,000 | $-17,115,000 |
| Cash Dividends Paid | $-27,362,000 | $-26,540,000 | $-24,128,000 | $-21,321,000 |
| Common Stock Dividend Paid | $-27,362,000 | $-26,540,000 | $-24,128,000 | $-21,321,000 |
| Net Common Stock Issuance | $-5,566,000 | $0 | $163,646,000 | $0 |
| Common Stock Issuance | $0 | $0 | $163,646,000 | $0 |
| Dividends Received Cfi | $1,411,000 | $1,080,000 | $830,000 | $1,259,000 |
| Other | ||||
| Repayment Of Debt | $-181,440,000 | $-14,702,000 | $-63,150,000 | $-186,805,000 |
| Issuance Of Debt | $189,500,000 | $19,000,000 | $24,000,000 | $251,000,000 |
| Interest Paid Supplemental Data | $9,431,000 | $7,209,000 | $8,655,000 | $5,687,000 |
| Income Tax Paid Supplemental Data | $14,348,000 | $4,823,000 | $4,926,000 | $7,615,000 |
| End Cash Position | $35,570,000 | $41,362,000 | $152,825,000 | $31,594,000 |
| Beginning Cash Position | $41,362,000 | $152,825,000 | $31,594,000 | $28,567,000 |
| Changes In Cash | $-5,792,000 | $-111,463,000 | $121,231,000 | $3,027,000 |
| Common Stock Payments | $-5,566,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $8,060,000 | $4,298,000 | $-39,150,000 | $64,195,000 |
| Net Long Term Debt Issuance | $8,060,000 | $4,298,000 | $-39,150,000 | $64,195,000 |
| Long Term Debt Payments | $-181,440,000 | $-14,702,000 | $-63,150,000 | $-186,805,000 |
| Long Term Debt Issuance | $189,500,000 | $19,000,000 | $24,000,000 | $251,000,000 |
| Net Business Purchase And Sale | $-24,948,000 | $-142,038,000 | $-36,872,000 | $-74,280,000 |
| Sale Of Business | $916,000 | $105,000 | $977,000 | $775,000 |
| Purchase Of Business | $-25,864,000 | $-142,143,000 | $-37,849,000 | $-75,055,000 |
| Net PPE Purchase And Sale | $-14,071,000 | $-9,186,000 | $-9,294,000 | $-8,248,000 |
| Purchase Of PPE | $-14,071,000 | $-9,186,000 | $-9,294,000 | $-8,248,000 |
| Change In Working Capital | $-27,190,000 | $-12,404,000 | $-4,929,000 | $-21,735,000 |
| Change In Other Current Liabilities | $86,000 | $-1,405,000 | $1,254,000 | $2,546,000 |
| Change In Other Current Assets | $-10,418,000 | $-818,000 | $-197,000 | $-5,940,000 |
| Change In Payables And Accrued Expense | $-7,798,000 | $1,713,000 | $15,000 | $-7,755,000 |
| Change In Receivables | $-9,060,000 | $-11,894,000 | $-6,001,000 | $-10,586,000 |
| Changes In Account Receivables | $-11,955,000 | $-5,346,000 | $-5,645,000 | $-10,279,000 |
| Other Non Cash Items | $-4,377,000 | $723,000 | $-612,000 | $-2,293,000 |
| Stock Based Compensation | $8,270,000 | $7,823,000 | $7,236,000 | $7,264,000 |
| Provisionand Write Offof Assets | $7,647,000 | $6,912,000 | $6,172,000 | $5,548,000 |
| Asset Impairment Charge | $0 | $2,418,000 | $17,495,000 | $9,112,000 |
| Deferred Tax | $11,406,000 | $5,365,000 | $4,490,000 | $4,309,000 |
| Deferred Income Tax | $11,406,000 | $5,365,000 | $4,490,000 | $4,309,000 |
| Depreciation Amortization Depletion | $22,391,000 | $18,681,000 | $15,695,000 | $14,743,000 |
| Depreciation And Amortization | $22,391,000 | $18,681,000 | $15,695,000 | $14,743,000 |
| Earnings Losses From Equity Investments | $-1,477,000 | $-1,014,000 | $-955,000 | $-1,175,000 |
| Gain Loss On Sale Of PPE | $383,000 | $836,000 | $166,000 | $-643,000 |
| Net Income From Continuing Operations | $58,005,000 | $45,600,000 | $37,220,000 | $43,407,000 |
| Gain Loss On Sale Of Business | - | - | - | $0 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |